Literature DB >> 26614371

Surgical Management of Pancreatic Neuroendocrine Tumors.

Thomas E Clancy1.   

Abstract

Pancreatic neuroendocrine tumors (PNETs) are uncommon tumors with a range of clinical behavior. Some PNETs are associated with symptoms of hormone secretion, with increased systemic levels of insulin, gastrin, glucagon, or other hormones. More commonly, PNETs are nonfunctional, without hormone secretion. Surgical resection is the mainstay of therapy, particularly for localized disease. Surgical therapy must be tailored to tumor and clinical characteristics. Resection may be particularly indicated in the setting of hormone hypersecretion. Small, incidental PNETs are increasingly managed nonoperatively. Surgery may also be indicated in some instances of metastatic disease, if all metastatic foci may be removed.
Copyright © 2016 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Enucleation; Neuroendocrine; Pancreas; Pancreatectomy; Surgery

Mesh:

Substances:

Year:  2015        PMID: 26614371     DOI: 10.1016/j.hoc.2015.09.004

Source DB:  PubMed          Journal:  Hematol Oncol Clin North Am        ISSN: 0889-8588            Impact factor:   3.722


  7 in total

Review 1.  Pancreatic neuroendocrine tumors.

Authors:  Jian Sun
Journal:  Intractable Rare Dis Res       Date:  2017-02

Review 2.  Pancreatic Neuroendocrine Tumors (panNETs): Analysis of Overall Survival of Nonsurgical Management Versus Surgical Resection.

Authors:  Paige Finkelstein; Rishika Sharma; Omar Picado; Rahul Gadde; Heather Stuart; Caroline Ripat; Alan S Livingstone; Danny Sleeman; Nipun Merchant; Danny Yakoub
Journal:  J Gastrointest Surg       Date:  2017-03-02       Impact factor: 3.452

3.  Short- and long-term outcomes of laparoscopic organ-sparing resection in pancreatic neuroendocrine tumors: a single-center experience.

Authors:  Javier A Cienfuegos; Joseba Salguero; Jorge M Núñez-Córdoba; Miguel Ruiz-Canela; Alberto Benito; Sira Ocaña; Gabriel Zozaya; Pablo Martí-Cruchaga; Fernando Pardo; José Luis Hernández-Lizoáin; Fernando Rotellar
Journal:  Surg Endosc       Date:  2017-01-26       Impact factor: 4.584

4.  Natural History and Treatment Trends in Pancreatic Cancer Subtypes.

Authors:  Courtney J Pokrzywa; Daniel E Abbott; Kristina A Matkowskyj; Sean M Ronnekleiv-Kelly; Emily R Winslow; Sharon M Weber; Alexander V Fisher
Journal:  J Gastrointest Surg       Date:  2019-01-31       Impact factor: 3.452

5.  Differentiation of atypical pancreatic neuroendocrine tumors from pancreatic ductal adenocarcinomas: Using whole-tumor CT texture analysis as quantitative biomarkers.

Authors:  Jiali Li; Jingyu Lu; Ping Liang; Anqin Li; Yao Hu; Yaqi Shen; Daoyu Hu; Zhen Li
Journal:  Cancer Med       Date:  2018-08-27       Impact factor: 4.452

6.  Pancreatic neuroendocrine tumor, lymphoma, and squamous cell carcinoma of hypopharynx; A case report of three primary cancers in one patient.

Authors:  Vorapatu Tangsirapat; Kitti Wongta; Kobkool Chakrapan Na Ayudhya; Vichack Chakrapan Na Ayudhya; Paiboon Sookpotarom
Journal:  Int J Surg Case Rep       Date:  2019-11-02

7.  Reappraisal of a 2-cm Cutoff Size for the Management of Nonfunctional Pancreatic Neuroendocrine Tumors: A Population-Based Study.

Authors:  Zhen Yang; Dongsheng Zhang; Guangjun Shi
Journal:  Front Endocrinol (Lausanne)       Date:  2022-07-18       Impact factor: 6.055

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.